Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine versus tolterodine versus placebo in women with urge urinary incontinence
2004-002143-27Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urge incontinence comparing Yentreve arm, Detrusitol retard arm and Placebo arm (3 arms). Primary endpoints: Mean change from baseline to endpoint in incontinence episode frequency and Patient global perception of treatment effect. Started Jan 2005; status: completed.
02
Drugs
duloxetinetolterodine
03
Conditions
urge incontinence
Beyond the preview
Go deeper on 2004-002143-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002143-27.